Literature DB >> 12917513

Bladder cancer recurrence: Part II. What do I tell my patients about lifestyle changes and dietary supplements?

Mark A Moyad1.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to provide the clinician with an adequate summary of current potential recommendations for reducing the risk of bladder cancer recurrence so that this topic can be discussed with patients that are dealing with this specific situation. RECENT
FINDINGS: Several potential novel methods to reduce the risk of recurrence should be discussed with patients. Non-selective and selective cyclo-oxygenase 2 inhibitors have preliminary data from from laboratory and epidemiologic investigations. Several preliminary trials have found that a combination dietary supplement of vitamins and minerals or a probiotic agent (Lactobacillus casei) may impact recurrence rates. Smoking cessation may be one of the best routes for reducing recurrence and reducing the risk of overall early morbidity and mortality. Garlic or fluid intake need more clinical data.
SUMMARY: Clinical recommendations for reducing the risk of bladder cancer recurrence need more attention. Preliminary data seem to support a potential role of numerous lifestyle and dietary supplement regimens. In the future, more reviews on the potential impact of reducing recurrence should be separated from reviews on prevention because these can be confusing when treated as a single subject.

Entities:  

Mesh:

Year:  2003        PMID: 12917513     DOI: 10.1097/00042307-200309000-00004

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  2 in total

1.  Patient awareness of smoking as a risk factor for bladder cancer.

Authors:  Ioannis Anastasiou; Vasilios Mygdalis; Anastasios Mihalakis; Ioannis Adamakis; Constantinos Constantinides; Dionisios Mitropoulos
Journal:  Int Urol Nephrol       Date:  2009-07-10       Impact factor: 2.370

2.  Inhibiting invasion into human bladder carcinoma 5637 cells with diallyl trisulfide by inhibiting matrix metalloproteinase activities and tightening tight junctions.

Authors:  Dong Yeok Shin; Hee-Jae Cha; Gi-Young Kim; Wun-Jae Kim; Yung Hyun Choi
Journal:  Int J Mol Sci       Date:  2013-10-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.